SCHEMBL7501660

SCHEMBL7501660

CCCc1cccc(CCc2oc(C)nc2C(=O)O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SORT1 Q99523 1/20 0.40
SLC7A11 Q9UPY5 1/20 0.38
MAPT P10636 2/20 0.36
ESR1 P03372 1/20 0.36
MAPK10 P53779 1/20 0.36
KMT2A Q03164 1/20 0.36
LONP1 P36776 1/20 0.35
PDE10A Q9Y233 1/20 0.35
KAT6A Q92794 1/20 0.35
P2RX3 P56373 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 2/20 0.34
HSD17B10 Q99714 1/20 0.34
NPC1 O15118 1/20 0.34
POLB P06746 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NOS1 P29475 1/20 0.34
NOS2 P35228 1/20 0.34
MTNR1A P48039 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7508066 0.92 BCL2 (0.40) SLC7A11MAPTESR1MAPK10KMT2A
SCHEMBL7512877 0.88 NR3C2 (0.45) SLC7A11KMT2AALDH1A1NPC1RAB9A
SCHEMBL11741106 0.86 P2RX3 (0.44) SLC7A11MAPTESR1MAPK10KMT2A
SCHEMBL7508419 0.86 ALDH1A1 (0.47) KMT2AALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL754250 0.77 EGLN1 (0.42) KMT2AALDH1A1POLBSMN1; SMN2
SCHEMBL27882116 0.76 RNASEH1 (0.46) MAPTESR1MAPK10KMT2AALDH1A1
SCHEMBL11747526 0.75 P2RX3 (0.40) MAPTESR1MAPK10KMT2AP2RX3
SCHEMBL11739215 0.75 ALDH1A1 (0.50) MAPTKMT2AKDM4EALDH1A1HSD17B10
SCHEMBL4806017 0.74 FBP1 (0.43) ALDH1A1
SCHEMBL11829444 0.73 CES1 (0.45) MAPTKDM4EALDH1A1HSD17B10RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042320-B1 NEW COMPOUNDS WHICH ARE P2-PURINOCEPTOR 7-TRANSMEMBRANE (TM) G-PROTEIN COUPLED RECEPTOR ANTAGONISTS ASTRAZENECA UK LTD (GB) 2002-02-13 EP disclosed
US-6218376-B1 FOR TREATING INFLAMMATORY DISEASES ASTRAZENECA UK LIMITED (GB) 2001-04-17 US disclosed
EP-1042320-A1 NEW COMPOUNDS WHICH ARE P2-PURINOCEPTOR 7-TRANSMEMBRANE (TM) G-PROTEIN COUPLED RECEPTOR ANTAGONISTS AstraZeneca UK Limited (GB) 2000-10-11 EP disclosed
WO-1999026944-A1 NEW COMPOUNDS WHICH ARE P2-PURINOCEPTOR 7-TRANSMEMBRANE (TM) G-PROTEIN COUPLED RECEPTOR ANTAGONISTS ASTRAZENEKA UK LIMITED (GB) 1999-06-03 WO disclosed